Cristina Rodriguez
University of Washington

Last Updated On 6/4/2021 9:44:06 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: AstraZeneca
Recipient: An Immediate Family Member
Company: beigene
Recipient: An Immediate Family Member
Company: Karyopharm Therapeutics
Recipient: An Immediate Family Member
Company: Kite, a Gilead company
Recipient: An Immediate Family Member
Company: Incyte
Recipient: An Immediate Family Member
Company: Millenium Pharamceuticals
Recipient: An Immediate Family Member
Company: Millenium Pharamceuticals
Recipient: An Immediate Family Member
Company: ADC Therapeutics
Recipient: An Immediate Family Member

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Merck
Recipient: Your Institution
Company: AstraZeneca/MedImmune
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Ignyta
Recipient: Your Institution
Company: Ayala
Recipient: Your Institution
Company: CUE Biopharma
Recipient: Your Institution
Company: Kura
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered